Mounjaro®
Starting from £179.99/mo
Start journey Learn moreRapid weight loss on semaglutide can make some people look older in the short term, particularly in the face. This is not unique to Wegovy — it happens with any significant weight loss, and the underlying reason is well-understood: fat beneath the skin contributes to volume and firmness, and when it goes, it goes everywhere. That said, the picture is more nuanced than a simple yes or no, and whether it applies to you depends on how much weight you lose, your age, your skin's natural elasticity, and the pace of change. Wegovy (semaglutide) is a prescription-only medicine and any decision to use it involves a clinical assessment of your individual circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a scenario our prescribers hear regularly. Someone loses weight, feels genuinely better, and then a well-meaning friend says they look gaunt. The honest explanation: subcutaneous fat (the soft layer beneath your skin) is not just stored energy. It acts as scaffolding. In the face, it fills out cheeks, softens the under-eye area and keeps the jawline looking defined. Lose it quickly and the skin above it can sag before it has time to adjust.
Semaglutide, the active medicine in Wegovy, works by reducing appetite and slowing gastric emptying. The weight loss it produces is real and often substantial. The how semaglutide works page covers the mechanism in full, but the short version is that your body loses fat from wherever it's stored (including the face) and it doesn't take requests about the order. This is the same process seen with any significant weight reduction, whether from surgery, low-calorie diets or GLP-1 medicines. The medicine isn't ageing your skin; the weight loss is redistributing volume.
The NHS notes that loss of facial volume is a recognised cosmetic concern with weight-loss medicines, though it is not classed as a medical side effect in the same bracket as nausea or gallbladder problems. Whether it happens to a noticeable degree depends heavily on your starting age, how much weight you lose overall, and how fast.
Skin elasticity declines naturally from the mid-thirties onwards. Collagen and elastin (the structural proteins that let skin spring back) are produced more slowly as you age. Someone losing three stone in their forties may see more facial looseness than someone the same weight losing the same amount in their late twenties, simply because their skin has less rebound capacity.
Pace matters considerably. Gradual loss gives skin time to adapt. Wegovy's titration schedule (starting at a low dose and increasing incrementally, with the prescriber guiding the pace) can mean weight loss happens over many months rather than weeks, which tends to be kinder to skin. Arriving at a faster loss by any method compresses that adaptation window.
Body composition is the other factor people underestimate. Significant muscle loss alongside fat loss produces a hollower, more fatigued appearance than fat loss alone. Protein intake and some form of resistance activity throughout treatment are the practical levers here. A prescriber or dietitian can advise on what's realistic for your situation. There's also a separate question about how Wegovy affects overall appearance and wellbeing, the changes people notice on Wegovy page looks at that more broadly.
For many people, yes. Skin is adaptive tissue. Once weight stabilises, skin gradually remodels over a period of months. The face in particular tends to recover better than areas with greater skin surface area like the abdomen or inner thighs. How complete that recovery is depends on the same variables: age, total weight lost, genetics, sun exposure history and general skin health.
There are practical things that support recovery: adequate hydration, sufficient dietary protein (which provides the amino acids skin needs to rebuild collagen), and protecting against UV damage, which breaks down elastin faster than almost anything else. None of these are treatment recommendations from us, they're general evidence-based skincare principles.
Some people choose to discuss the facial appearance concern with a dermatologist or aesthetic practitioner once their weight has stabilised. That is a separate clinical conversation, and well outside what a weight-loss prescriber would advise on. If you're weighing up the cosmetic trade-offs of treatment, the detailed look at Wegovy and facial ageing covers the evidence in more depth, and there's a related page on whether Wegovy makes you look older generally if you want to read them alongside each other.
It would be disingenuous to dismiss this. Some people do feel self-conscious about facial changes during weight loss, and that's a legitimate part of the picture when making a treatment decision. At the same time, the health gains from sustained weight reduction (improved blood pressure, better sleep, reduced joint load, lower cardiovascular risk) are substantial and well-documented. A temporary cosmetic adjustment, for most people, sits differently once you weigh it against those outcomes.
Cost is another practical question people bring to this decision. The Wegovy pricing page sets out what to expect from private treatment in the UK, including what a legitimate price actually covers, and if you're curious about the company behind the medicine, there's a page covering who owns Wegovy that some people find useful context before committing to treatment. A full clinical assessment is always part of that.
Our prescribers review each consultation personally (a real clinician reads your answers, not a system processing a form) and they're the right people to talk through concerns like this one. If you'd like to explore whether Wegovy suits your situation, you can speak to our prescribers through a free consultation. The assessment is free, there's no obligation, and if treatment is right for you, your prescription is issued the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.